Meeting
2014 ASCO Quality Care Symposium
Reporting on quality indicators in renal cell carcinoma: Proportion of metastatic patients who initially commence on full-dose targeted therapy.
Authors
Lori Wood
Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
Lori Wood, Daniel Yick Chin Heng, Jennifer J. Knox, Georg A. Bjarnason, Christian K. Kollmannsberger, Anil Kapoor, Sebastien J. Hotte, Marie Vanhuyse, Piotr Czaykowski, Denis Soulieres, Antonio Finelli, Zhihui Liu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Science of Quality and Cost, Value, and Policy in Quality
Track
Science of Quality,Cost, Value, and Policy in Quality
Sub Track
Quality Measurement
Citation
J Clin Oncol 32, 2014 (suppl 30; abstr 265)
DOI
10.1200/jco.2014.32.30_suppl.265
Abstract #
265
Poster Bd #
F6
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Pancreatic metastases from renal cell carcinoma: Prognostic relevance and outcome in patients treated with targeted agents.
First Author: Paolo Grassi
Poster
2014 Genitourinary Cancers Symposium
Duration of targeted therapy in metastatic renal cell carcinoma patients with ECOG PS>2.
First Author: Ilya Tsimafeyeu
Poster
2012 Genitourinary Cancers Symposium
A population-based overview of sequences of targeted therapy in metastatic renal cell carcinoma (mRCC).
First Author: Daniel Yick Chin Heng
Poster
2015 Genitourinary Cancers Symposium
Prognosis and outcome of patients with pancreatic metastases from renal cell carcinoma: When the site matters.
First Author: Paolo Grassi